Market closed · After hours · 4:21 PM ET
Last update: Aug 10, 2026, 3:33 PM ET
Viatris Inc.
$16.28 0.91% today
After Hours

Why Viatris Inc. (VTRS) stock moved

Updated Aug 10, 2026

Viatris Inc. (VTRS) shares fell 0.9% to $16.28 as of August 10, 2026, a slight decline from the prior close of $16.43. BestStocks flagged the session as a major change for VTRS. Below, we break down what changed for VTRS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

VTRS fell 0.9% to $16.28

VTRS fell 0.9% in its latest session, moving from $16.43 to $16.28.

RiskLow confidence
Rel. volume
1.2×
Normal
Vs peers
No comparable peers
Market cap
$19.0B
NASDAQ Global Select
Analyst target
$21
+29.0% vs price
Price chart
Jul 10 – Aug 10
VEVVVEV$16$17$18Jul 10Jul 17Jul 27Aug 3Aug 10
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Viatris Inc. investors

For Viatris Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum; Viatris Inc. (VTRS) moved +3.53% from $16.99 to $17.59 on July 21, 2026, reaching a new 30-day high. Weighing against that: Material negative event; Negative session, down 0.9%. Wall Street's consensus price target sits at $21.00, implying +29.0% upside from $16.28. BestStocks rates the overall signal quality low (40/100). With earnings roughly 87 days out, the next report is the most likely near-term test of the move.

VTRS price reaction

VTRS last traded at $16.28, down $0.15 (-0.91%) from the previous close of $16.43. The session traded on 1.2× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $16.27 and $17.86, and it currently sits about 1% of the way up that band.

Bullish and bearish analyst opinions on Viatris Inc. (VTRS)

The consensus analyst price target on Viatris Inc. (VTRS) is $21.00, 29.0% above the recent $16.28. Over the past 90 days analysts logged 0 upgrades, 1 maintain, and 0 downgrades. Here is how the bullish and bearish cases on VTRS line up.

The bullish case

  • Wall Street's consensus price target of $21.00 implies +29.0% upside from $16.28.
  • The Street's most bullish target is $22.00 (+35.1%).
  • Positive price momentum.
  • Viatris Inc. (VTRS) moved +3.53% from $16.99 to $17.59 on July 21, 2026, reaching a new 30-day high.

The bearish case

  • Material negative event.
  • Negative session, down 0.9%.
  • VTRS moved -10.25% from its $18.15 open to a $16.29 close on 2026-08-06.
  • Viatris Inc. (VTRS) moved -3.30% from $17.59 to $17.01 on 2026-07-22.
Bull vs bear balanceBearish Shift
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Aug 10, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $21+29.0%
= 1 maintains
Barclays maintained Overweight · 2026-05-19
SEC filings watch
8-K2026-07-01
Material event — review for impact
high
8-K2026-06-18
Material event — review for impact
high
8-K2026-06-15
Material event — review for impact
high
8-K2026-05-15
Material event — review for impact
high
Peer context
VTRS-0.9%

Previous notable changes for VTRS

Material / Earnings2026-07-28+1.2%
Viatris Inc. (VTRS) moved +0.62% from $17.75 to $17.86 on 2026-07-28. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The stock reached a new 30-day high on volume near its 5-day average.
Activity2026-07-27+2.3%via Yahoo Finance
Viatris rose 2.41% to $17.66, tracking recent pipeline progress including positive Phase 3 results for VR-205 (Nefecon) targeting IgAN patients and FDA acceptances for new drug applications such as fast-acting meloxicam, according to market discussions cited by Yahoo Finance and investor relations sources. Volume of 5.7M shares ran 35% below the time-adjusted average, indicating modest underlying conviction.
Material / Earnings2026-07-23+1.6%
Viatris Inc. (VTRS) moved +3.04% from $16.77 to $17.28 on 2026-07-23. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, suggesting the move lacked significant institutional conviction.
Risk2026-07-22-3.3%
Viatris Inc. (VTRS) moved -3.30% from $17.59 to $17.01 on 2026-07-22. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.4x the 5-day average, indicating modest participation but no clear directional driver.
Upcoming catalysts & outlook
Next earnings
2026-11-05 (est.)
in 87 days
Thesis shift
Bearish Shift
bearish signal
Risk level
High
from change events

Frequently asked questions about VTRS

Why did Viatris Inc. (VTRS) stock move?

VTRS fell 0.9% to $16.28. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did VTRS stock fall?

VTRS lost 0.91% ($0.15) versus the prior close of $16.43, last trading at $16.28 on 1.2× average volume.

When is Viatris Inc.'s next earnings date?

VTRS's next earnings report is estimated for 2026-11-05 — about 87 days away.

What is the analyst price target for VTRS?

The consensus analyst price target for VTRS is $21.00, about 29.0% above the current $16.28. Over the past 90 days, analysts recorded 0 upgrades, 1 maintain, and 0 downgrades.

How BestStocks tracks VTRS

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared VTRS-specific materiality thresholds, triggering an evidence check. It draws on 13 tracked change events for VTRS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 10, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.